Antineoplastic agents. For the treatment of metastatic breast cancer and metastatic ovarian cancer. Broad-spectrum antineoplastic botanical, used to treat conditions such as ovarian cancer and breast cancer
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Semi-synthetic Paclitaxel is a taxane derivative produced via acylation of 10-deacetylbaccatin III extracted from <strong>Taxus</strong> species. This process ensures high purity and scalability compared to total synthesis.</p>
<ul>
<li><strong>Molecular Formula:</strong> C47H51NO14</li>
<li><strong>CAS Number:</strong> 33069-62-4</li>
</ul>
<h3>Application</h3>
<ul>
<li>Oncology: First-line therapy for metastatic breast, ovarian, and non-small cell lung cancers.</li>
<li>Pharmaceutical Manufacturing: Active Pharmaceutical Ingredient (API) for injectable formulations and nanoparticle complexes.</li>
<li>Research: Standard agent in preclinical studies regarding microtubule stabilization mechanisms.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly handled under PPE due to cytotoxicity; store at -20°C in desiccated conditions away from light. Requires specialized disposal protocols for hazardous waste.</p>